Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.

scientific article published in March 2009

Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID19212625

P2093author name stringXiao-Hua Zhang
Gui-Long Guo
Xiao-Qu Hu
Xian Shen
Jie You
Ka-Te Huang
Guan-Li Huang
Kai-Yan Yang
P433issue3
P304page(s)673-679
P577publication date2009-03-01
P1433published inOncology ReportsQ7092098
P1476titleClinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma
P478volume21

Reverse relations

cites work (P2860)
Q34252646A new strategy for identification of highly conserved microRNAs in non-model insect, Spodoptera litura
Q37022250Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor
Q52560790Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma
Q37413603Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA
Q37378012Current molecular diagnostics of breast cancer and the potential incorporation of microRNA
Q36057142Diagnostic, prognostic and predictive value of MicroRNA-21 in breast cancer patients, their daughters and healthy individuals.
Q87401555Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status
Q36110374Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer
Q42658857Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ
Q35105646High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients.
Q54356219Higher miR-21 expression in invasive breast carcinomas is associated with positive estrogen and progesterone receptor status in patients from Serbia.
Q36946688Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling
Q34036642Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines
Q37764166Micro-RNAs and breast cancer
Q36816367MicroRNA and cancer chemoprevention
Q38070646MicroRNA-21 gene and cancer
Q38163908MicroRNA-21 in breast cancer: diagnostic and prognostic potential
Q39407479MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.
Q86748477MicroRNA: A New Player for Cancer Chemoprevention
Q33585094MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment
Q38034670New NSAID targets and derivatives for colorectal cancer chemoprevention.
Q90376926Overview upon miR-21 in lung cancer: focus on NSCLC
Q39529523Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients
Q35713817Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast
Q36095156Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway
Q36677690Role of microRNAs in breast cancer
Q36317309Serum miR-21 level: a potential diagnostic and prognostic biomarker for non-small cell lung cancer
Q36024500Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs
Q37506648The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma
Q39258051The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion
Q51416072The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin.
Q36396579The role of microRNAs in breast cancer migration, invasion and metastasis
Q47104938The roles of ncRNAs in the diagnosis, prognosis and clinicopathological features of breast cancer: a systematic review and meta-analysis
Q47701015Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease
Q92711379Transregulation of microRNA miR-21 promoter by AP-1 transcription factor in cervical cancer cells
Q34575190miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis
Q38739495miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development.
Q92665798miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL Study
Q36224336microRNA expression pattern and its alteration following celecoxib intervention in human colorectal cancer
Q37760459microRNAs and EMT in mammary cells and breast cancer.
Q35185340microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis